Web Analytics and Web Statistics by NextSTAT Health Advances - Venture-backed Companies
Health Advances Logo
Sitemap
search this site
Home About Experience Approach Careers News Contact
Clinical Expertise
Functional Expertise
Industry Expertise
Biotechnology
Diagnostics
Discovery and Development
Drug Delivery
Medical Devices
Not-for-Profit Organizations
Pharmaceutical Companies
Private Equity Companies
Venture-Backed Companies
Focus Areas
Case Examples of Our Work with Venture-Backed Companies
Lysosomal Storage Diseases: Health Advances created a comprehensive plan for a university-based start-up company including an analysis of the market opportunity, evaluation of competitors, outline of the development and manufacturing plan, and preparation of a two-year staffing plan.

Stem Cell Expansion: Health Advances assisted with interactive business planning process to prepare the company for seeking its first significant round of institutional venture capital. Applications include immune system reconstitution for supplementation and gene therapy.

Uterine Fibroids Treatment: A start-up company had a medical device to be used as a non-surgical alternative to hysterectomies to treat uterine fibroids. Health Advances assisted with a market assessment, business plan, and launch plan, emphasizing on referral patterns and patient-directed promotion.

High-Throughput Screening: Health Advances assisted with early-stage planning for entry into the pharmaceutical research market for a company with a diversified business in thermogenic imaging with potential in high-throughput screening led to the spin-out of a new company and an equity partnership with one of the top five pharmaceutical companies.

Diabetes Diagnostic: Prior to embarking on a critical round of fundraising from private sources, an early-stage company in the highly competitive field of non-invasive glucose monitoring consulted Health Advances to assist them with strategy development.

Genomics/Proteomics: Investigation of growth strategies for a company in the research supplies business led to a comprehensive business plan for entering a dynamic new segment of the market. First envisioned as a spinout opportunity, the new opportunity became the core business for an entire division.

Protein Production Technology: Strategic plan for exploiting a novel technology for modifying the glycosylation pattern of proteins and antibodies that involved framing the opportunity, exploring potential partnerships and deal structures, and outlining the staffing and financing necessary to exploit the opportunity.
Contact Us
Health Advances All Rights Reserved.